Changjun Lv

5.1k total citations · 1 hit paper
119 papers, 4.2k citations indexed

About

Changjun Lv is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Changjun Lv has authored 119 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pulmonary and Respiratory Medicine, 48 papers in Molecular Biology and 30 papers in Cancer Research. Recurrent topics in Changjun Lv's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (45 papers), Cancer-related molecular mechanisms research (18 papers) and Circular RNAs in diseases (14 papers). Changjun Lv is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (45 papers), Cancer-related molecular mechanisms research (18 papers) and Circular RNAs in diseases (14 papers). Changjun Lv collaborates with scholars based in China, United States and South Korea. Changjun Lv's co-authors include Lingxin Chen, Fabiao Yu, Jaebum Choo, Min Gao, Xiaodong Song, Jinjin Zhang, Meirong Wang, Xinyu Song, Pan Xu and Xiaozhi Wang and has published in prestigious journals such as Chemical Society Reviews, ACS Nano and PLoS ONE.

In The Last Decade

Changjun Lv

113 papers receiving 4.2k citations

Hit Papers

Fluorescent chemical probes for accurate tumor diagnosis ... 2017 2026 2020 2023 2017 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy
    2017 743 citations Changjun Lv, Lingxin Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changjun Lv China 38 1.7k 968 838 696 583 119 4.2k
Giovanni Miotto Italy 30 2.0k 1.2× 926 1.0× 434 0.5× 474 0.7× 388 0.7× 66 3.5k
Jian Zhang China 33 1.3k 0.8× 440 0.5× 260 0.3× 554 0.8× 360 0.6× 246 4.0k
Giorgio Minotti Italy 45 2.9k 1.7× 797 0.8× 489 0.6× 543 0.8× 573 1.0× 152 9.7k
Fei Yan China 43 2.5k 1.5× 427 0.4× 838 1.0× 1.2k 1.7× 602 1.0× 202 5.4k
Zeping Hu China 42 3.6k 2.2× 429 0.4× 1.5k 1.8× 317 0.5× 179 0.3× 90 6.3k
José M. Estrela Spain 44 3.1k 1.9× 475 0.5× 648 0.8× 472 0.7× 341 0.6× 88 6.5k
Yongmei Xie China 35 1.6k 0.9× 177 0.2× 250 0.3× 342 0.5× 477 0.8× 159 3.7k
Ling Dong China 40 2.3k 1.4× 357 0.4× 956 1.1× 557 0.8× 287 0.5× 155 4.8k
Michael R.L. Stratford United Kingdom 33 2.0k 1.2× 476 0.5× 913 1.1× 700 1.0× 201 0.3× 99 4.4k
Yinglan Zhao China 40 2.9k 1.8× 339 0.4× 1.3k 1.5× 263 0.4× 275 0.5× 160 5.4k

Countries citing papers authored by Changjun Lv

Since Specialization
Citations

This map shows the geographic impact of Changjun Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changjun Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changjun Lv more than expected).

Fields of papers citing papers by Changjun Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changjun Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changjun Lv. The network helps show where Changjun Lv may publish in the future.

Co-authorship network of co-authors of Changjun Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Changjun Lv. A scholar is included among the top collaborators of Changjun Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changjun Lv. Changjun Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Juan, Na Zhang, Wenjing Ren, et al.. (2025). Effect of chronic intermittent hypoxia on hippocampal lipid metabolism in mice: A targeted lipidomics study. Brain Research Bulletin. 224. 111319–111319.
2.
3.
Yang, Bing, Ji Liu, Changjun Lv, et al.. (2025). Integrated multi-omics analysis reveals PTM networks as key regulators of colorectal cancer progression and immune evasion. Discover Oncology. 16(1). 1725–1725.
4.
Liu, Weili, et al.. (2025). circ0066187 promotes pulmonary fibrogenesis through targeting STAT3-mediated metabolism signal pathway. Cellular and Molecular Life Sciences. 82(1). 79–79. 1 indexed citations
5.
Ji, Yunxia, Yunqing Wang, Jinjin Zhang, et al.. (2024). Realistic Nanoplastics Induced Pulmonary Damage via the Crosstalk of Ferritinophagy and Mitochondrial Dysfunction. ACS Nano. 18(26). 16790–16807. 34 indexed citations
6.
Ren, Wenjing, Na Zhang, Yunliang Sun, et al.. (2023). The REM microarousal and REM duration as the potential indicator in paradoxical insomnia. Sleep Medicine. 109. 110–117. 2 indexed citations
7.
Zhang, Tingwei, Bo Liu, Qian Zhang, et al.. (2023). Proteomic analysis reveals the aging-related pathways contribute to pulmonary fibrogenesis. Aging. 15(24). 15382–15401. 1 indexed citations
8.
Zhang, Songzi, Weili Liu, Ruiqiong Li, et al.. (2023). circELP2 reverse‐splicing biogenesis and function as a pro‐fibrogenic factor by targeting mitochondrial quality control pathway. Journal of Cellular and Molecular Medicine. 28(3). e18098–e18098. 7 indexed citations
9.
Liu, Jianghua, Xiao Li, Yunliang Sun, et al.. (2023). Validation of a portable monitor compared with polysomnography for screening of obstructive sleep apnea in polio survivors. Frontiers in Neurology. 14. 1137535–1137535. 1 indexed citations
10.
Xu, Pan, Bo Liu, Rongrong Li, et al.. (2022). MOBT Alleviates Pulmonary Fibrosis through an lncITPF–hnRNP-l-Complex-Mediated Signaling Pathway. Molecules. 27(16). 5336–5336. 2 indexed citations
11.
12.
He, Na, et al.. (2020). A near-infrared fluorescent probe for evaluating glutamyl transpeptidase fluctuation in idiopathic pulmonary fibrosis cell and mice models. Sensors and Actuators B Chemical. 322. 128565–128565. 29 indexed citations
13.
Li, Wanting, Dongze Li, Jidong Fang, et al.. (2020). TLR2 deficiency attenuated chronic intermittent hypoxia-induced neurocognitive deficits. International Immunopharmacology. 81. 106284–106284. 10 indexed citations
14.
Pan, Lei, Jun‐Hong Yan, Hong Li, et al.. (2019). Case report of a 28-year-old man with aortic dissection and pulmonary shadow due to granulomatosis with polyangiitis. BMC Pulmonary Medicine. 19(1). 122–122. 7 indexed citations
15.
Zhang, Jie, et al.. (2018). Astilbin ameliorates pulmonary fibrosis via blockade of Hedgehog signaling pathway. Pulmonary Pharmacology & Therapeutics. 50. 19–27. 25 indexed citations
16.
17.
18.
Zhang, Guanghua, et al.. (2016). Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo. Phytomedicine. 23(4). 350–358. 27 indexed citations
19.
Li, Xinxin, Pingyu Wang, Xue Zhou, et al.. (2015). Reduced expression levels of let-7c in human breast cancer patients. Oncology Letters. 9(3). 1207–1212. 33 indexed citations
20.
Liu, Xiaoli, et al.. (2009). Low-dose heparin on treatment of sepsis in hypercoagulable period. Chinese Journal of Asthma. 29(15). 917–919. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Miotto Breakdown of academic impact, for papers by Jian Zhang Breakdown of academic impact, for papers by Giorgio Minotti Breakdown of academic impact, for papers by Fei Yan Breakdown of academic impact, for papers by Zeping Hu Breakdown of academic impact, for papers by José M. Estrela Breakdown of academic impact, for papers by Yongmei Xie Breakdown of academic impact, for papers by Ling Dong Breakdown of academic impact, for papers by Michael R.L. Stratford Breakdown of academic impact, for papers by Yinglan Zhao
Rankless by CCL
2026